chrisvoncsefalvay/vaers-outcomes huggingface dataset:
elbow joint pain; Mild pain at area of injection; This is a spontaneous report from a contactable consumer (patient). A 51-year-old non-pregnant female patient received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration, administered in the left arm on 12Mar2021 at 14:00 (Lot Number: ENG6202) as dose 1, single for COVID-19 immunization. The patient did not have any medical history and had no known allergies. The patient did not have COVID prior to vaccination. The patient was not tested for COVID post vaccination. Concomitant medications included vitamin b complex (manufacturer unknown); curcuma longa (TURMERIC, manufacturer unknown) and cetirizine (manufacturer unknown), all taken for an unspecified indication, start and stop date were not reported. On 12Mar2021 at 17:00, the patient experienced mild pain at area of injection and elbow joint pain. The patient did not receive treatment for the events. The outcome of the events was not recovered.   No follow-up attempts are possible. No further information is expected.
Itchiness at first around where the shot was given. Followed by a large hard lump (about the size of a large egg) under the skin. Hot to the touch. Redness about the size of a softball around the hard area.
I had 3 mouth ulcers on my tongue and they appeared 5 days after the 3rd dose of the vaccine. I went to the urgent care. He prescribed steroids and antiviral medicine and it resolved within 3-4 days. I did have a COVID-19 test done at the urgent which came back negative. I also had mild body aches, fever, and general fatigue.
My first Pfizer vaccine was given on January 18th, 2021 at my previous place of employment. Due to those circumstances and never finding an opening, I went to CVS in Atlantic City to receive my Pfizer dose #2.    I feel like a train hit me. Today equals one week since my second dose. Headache, fatigue, body aches, chills and runny nose.
Child said she had fever, body aches and shortness of breath in the middle of night for 3 hrs.
Information has been received from a caller concerning her daughter, a 22-year-old female patient with codeine allergy and no pertinent medical history who on "January of 2010" was vaccinated with the first dose of GARDASIL. The patient received the second dose on an unspecified date. Concomitant therapy included PLAQUENIL, prednisone, HUMIRA and YASMIN. In "June of 2010", she developed arthritis, lupus, Sjorgens, and also developed warts on her body. The patient went to see an arthritis specialist and a dermatologist. She performed blood work and x rays, which result not provided. The patient did not get her third shot of GARDASIL and arthritis, lupus, Sjorgens and warts on her body persisted. Upon internal review, the patient's lupus was considered to be an other important medical event. Additional information has been requested.
at 1550 BP was 144/81, O2 sat 94%.  C/O lightheadedness, nausea and sever headache.  Denies weakness, no facial droop noted and no dysphasia noted.  at 1600 BP 138/91, Pulse 91, R is 6, O2 92%.  Denies lightheadedness or nausea.  unstable when trying to stand.  At 1620 sitting BP=156/92, Pulse 90 and R were 16/min.  Reported mild lightheadedness.  Leaning way back in chair and closing her eyes whenever she sits down.  patient stating that she was okay to leave on her own.  Denies that she has someone to help her to get home.  Asking this RN to call her PCP.  This RN overheard her speaking to her PCP's office and staff member stating that he was gone for the day and that he would want her to be evaluated in the ED.
Patient was given Moderna COVID-19 Vaccine and age was only 16 years old.  Error was realized after the fact. Attempted to call patient to notify. No answer and unable to leave voicemail. Called NC Immunization Branch and notified.
0920, reporteed thickness in back of tonge,c/o  trouble swollowing, able to drink water, 126/72, hr83, 02 sat 96% RA, rr 16 Called rapid response, NP assessed and rec ER, pt refused.  0940 Benedry 50 mg po given.  Refused ER again,  Agrreded to monitor until 11am  Checked out At 11:10.  Denied other symptoms.
Information has been received from a nurse practitioner (NP) concerning a 10-year-old male student with attention deficit/hyperactivity disorder (ADHD) and no known allergies who on 12-NOV-1999 was vaccinated SC in the left arm with a 0.5 mL first dose of Varivax (Lot #631071/1002J). Concomitant therapy included ADDERALL. There was no illness at the time of vaccination. The NP reported that on 11-MAY-2006, the patient developed spots all over. He was seen in the office with several pustules with one scabbed over, red itchy, raised rash, early stage varicella and low grade temperature. There were approximately 16-24 lesions and papules over his arms and torso with three on his face in various stages. He was treated with Aveeno Bath, BENADRYL and TYLENOL or MOTRIN. No laboratory/diagnostic tests were performed. On 15-MAY-2006, the patient recovered. Additional information is not expected.
40 minutes after receiving the shot my face felt like it was swelling.  It felt like my left side of my face swelled first and then 3 minutes later if felt like it generalized to the entire face. (I received the shot on my left side) I also felt some faint tingling in my mouth.  Looking in the mirror, I couldn't tell if it was swollen but my sensation of my skin was swollen & tight.  After about 10 minutes it felt like it was easing off.  A hour later my face felt a little tingly like a Novocain shot had almost worn off. After 3 hours, I felt normal.   Then day 2 & 3: a sore arm. Then day 4: muscle aches, fatigue & headache.
5mins post vaccination, pt reported flushing/sweating and headache.  No S/S distress.  VSS.  Once taken to medical area and given water, symptoms subsided.  No further complaints.  Partents instructed to call 911 if pt has any respiratory distress.  Pt released in stable condition.  Strong steady gait Vitals: 17:41 118/76, 103, 100% -- > 17:46 111/76
5 days s/p FLUARIX vaccine developed dysphagia, SOB, erythema (confluent) to upper torso, back and face.
really bad headache; A spontaneous report was received from a consumer concerning a 69-year-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273)  experienced really bad headache. Concomitant medications were not reported  No relevant medical history  On 15-FEB- 2021, the patient received their first of two planned doses of mRNA-1273 (Batch number: UNKNOWN) intramuscularly  for prophylaxis of COVID-19 infection.    On 15-FEB- 2021, the patient experienced events like really bad headache.  No treatment for the event is reported   Action taken with mRNA-1273 in response to the events was not reported.     The events, headache were considered unknown serious criteria
Information has been received from a pharmacist referring to a male patient of unknown age. On unknown dates, the patient's wife and two children each received one dose of VARIVAX (Merck) (route, dose and lot# were unknown). The patient was unvaccinated and experienced shingles (secondary transmission) on an unknown date. The patient sought medical attention via contacting pharmacist. The outcome of the events was unknown. The causality was not reported. Additional information has been requested.
A report was received from a health care professional on 19Nov02 concerning a group of less than 10 vaccinees all less than 4 years old who were inadvertently administered Fluvirin on various unreported dates. On unreported dates less than 10 vaccinees less than 4 years were inadvertently administered Fluvirin. No adverse reaction was reported. There was insufficient information to determine the reporter's causality assessment.
Reported progressive bilateral weakness and tenderness to bilateral upper and lower extremities, with associated LUE and LLE twitching beginning 3 days after receipt of vaccination. Also notes persistent dyspnea on exertion. Patient reports symptoms mildly improved with over the counter ibuprofen. Patient referred to neurology for further evaluation, appointment pending.
Pt noted wheezing - 15 min after MENACTRA & Tdap. Known asthma. Diffuse wheeze on exam & felt itchy & given Epi & albut neb. Sx cleared & remain clear 2 hour after treatment.  Slight rash & fine papules. Allergist felt possible latex rxn.
stiffness and mild pain in the left side of the face discomfort when blinking / smiling slight "numbing" sensation in left side of face  Pain at injection site
injection site pain, tiredness, headache, muscle pain, chills, joint pain, injection site swelling, injection site redness, feeling unwell
Fever; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A patient with unspecified age and gender received bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/ lot number: not reported) via an unspecified route of administration on 29Mar2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that patient took the first dose of Pfizer Vaccine (Covid-19 Vaccine) yesterday on 29Mar2021 and on an unspecified date, patient experienced fever. Patient wanted know if that was COVID-19 or the side effects of vaccine. Patient was informed about Pfizer Medical information department and was provided with the number. Limited information was available over the call as the consumer was not willing to complete the report. Outcome of the event was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained. No further information is expected.
Developed muscle weakness and motor nerve inflammation in a GBS-like disease in the setting of lupus and recent vaccinations: Influenza 10/4/2021, COVID #1 10/8/21 and has received second one (exact date unknown), MCV4 10/4/21.  Reporting to VAERS for evaluation of relationship to vaccines.
Modern a COVID-19 Vaccine EUA Should and neck stiffness and pain.  Throat swelling.  Took ibuprophin and zyrtek
SWELLING IN LEFT NECK AREA WITH LYMPHEDEMA NOTED IN SHOULDER AREA.  BY 10/10/2010, SITE OF INJECTION BECAME RED AND PUFFY.  CONTINUED TO SWELL AND BECOME LARGER IN SIZE BY 10/13/2010 TO APPROX 10 MM OUTER CIRCUMFERENCE AND A BRIGHT RED SPOT INSIDE THE AREA THAT MEASURED APPROX 7 MM IN DIAMETER.  ENTIRE AREA ITCHED AND WAS PAINFUL TO TOUCH. PATIENT VISITED FAMILY DOCTOR ON 10/11/10 AND WAS PRESCRIBED AN ANTIBIOTIC FOR 2 DAYS.
PT STATED HE HAD LOCALIZED SWELLING, WARMTH, REDNESS AND STIFFNESS ON ARM, FOLLOWING DAY SWELLING HAD GONE DOWN BUT STILL INDURATED, PT TOOK TYLENOL WITH RELIEF. ON EVENING OF 2-6-18 ALL SYMTPOMS DISSIPATED.
he noticed that his vision has deteriorated; vision/getting fuzzy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), administration date 11Mar2021, around noon (Lot number: EN6206) as dose 1, single for covid-19 immunisation. Relevant medical history included: does wear glasses, but they were only for occasional use, until now. The patient's concomitant medications were not reported. The following information was reported: VISUAL IMPAIRMENT (non-serious) with onset 13Mar2021, outcome "unknown", described as "he noticed that his vision has deteriorated"; VISION BLURRED (non-serious) with onset 13Mar2021, outcome "unknown", described as "vision/getting fuzzy". The patient underwent the following laboratory tests and procedures: ophthalmological examination: (Nov2020) did not need any upgrade to his prescription. Additional information: on 13Mar2021, 2 days later from vaccination, while he was driving, he noticed that his vision has deteriorated and was getting fuzzy. He wants to know if anyone has experienced this reaction before. He said that it was his near and far-sightedness that was affected.  No follow-up attempts are possible. No further information is expected.
Rec'd 1st Shingrix late Nov. 2020. Rec'd Moderna COVID-19 mRNA vax 2/3 and  then on 3/5.  We (both my spouse and I) were advised by pharmacist to wait two weeks before getting 2nd Shingrix.  Both of us had very mild side effects from 1st Shingrix, and 1st Moderna mRNA, I had somewhat more side effects from 2nd Moderna COVID-19 but nothing extreme, my spouse had only a mild reaction to 2nd COVID-19 vax.  After our second Shingrix vax,  both my spouse and I had mildly sore arm only for about 10 hours after after the injection, then we both had multiple significant side-effects of body-wide muscle and joint aches, chills, headaches, extreme fatigue,  These side effects are slowly abating now 24 hours after they began.  So based on N=2 pts (my spouse and I), I now question if two weeks post second Moderna vax is insufficient time to avoid or minimize apparent cross-reactivity with our second Shingrix vax,  We both TXd our symptoms with Tylenol.
On 4/16, patient experienced brief seizure-like activity that resulted in ER visit. Discharged to home same day. EEG WNL
rash on legs & going to  arms; t104 <24 hrs p/vax;
When mom got home at 7:30 pm on 4/12, her left arm was very sore, extremely dizzy, then diarrhea, nausea, and weakness.  On 4/13, she was still very dizzy and weak.  On 4/14, she was extremely nauseated and very weak.  Other symptoms include a metallic taste, blurred vision, hoarseness, and a dry hacky cough.
Information was received from a registered nurse referring to a 15 year old patient of unknown gender. The patient's concomitant medication, pertinent medical history and drug allergy were not reported. At the age of 12 year old (in approximately 2015), the patient received GARDASIL (dose, route, lot# and expiration date not reported) for prophylaxis. Now three years later(in approximately 2018), the patient was returning to receive GARDASIL 9 (dose, route, lot# and expiration date not reported) for prophylaxis to complete the series( inappropriate schedule of vaccine administrated and interchange of vaccine products). No adverse effects reported. No product quality complaint was involved.
DIZZINESS; SLEEPINESS; LETHARGY; SLIGHT FEVER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced dizziness, sleepiness, lethargy, and slight fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dizziness, sleepiness, lethargy, and slight fever. This report was non-serious.
Information has been received from a physician and a nurse practitioner concerning a patient who about a month ago, July 2008, was inadvertently vaccinated with PNEUMOVAX 23 (lot# not reported) for 2nd dose in place of in place of PREVNAR. The nurse practitioner reported that the confusion was due to a miscommunication between the nurse and herself. She confirmed with the nurse that the patient should receive PREVNAR, when she actually meant PNEUMOVAX vaccine. Additional information has been requested.
Patient reported blue/bruised area around his injection site and he did bleed after the vaccine and he put his shirt down right away while the pharmacist was getting a bandaid so blood got on his shirt so he thought he was bleeding a lot.
soreness in left elbow joint; He was denied his second dose on 14APR2021 due to this side; This spontaneous case was reported by a consumer and describes the occurrence of INTENTIONAL DOSE OMISSION (He was denied his second dose on 14APR2021 due to this side) and ARTHRALGIA (soreness in left elbow joint) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced INTENTIONAL DOSE OMISSION (He was denied his second dose on 14APR2021 due to this side). On an unknown date, the patient experienced ARTHRALGIA (soreness in left elbow joint). On 14-Apr-2021, INTENTIONAL DOSE OMISSION (He was denied his second dose on 14APR2021 due to this side) had resolved. At the time of the report, ARTHRALGIA (soreness in left elbow joint) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment information was not provided.
Information has been received from a healthcare worker concerning a nurse regarding MMR II. The nurse was cut on shattered vials of vaccine received in a recent shipment. OMC is taking as a shipping issue. Additional information has been requested.
had 3 shots of the Pfizer COVID-19 Vaccine; had 3 shots of the Pfizer COVID-19 Vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID: (172086).  A male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Clotting disorders" (unspecified if ongoing), notes: Caller mentioned that her husband had clotting disorders and also had spent 100 days in the hospital in the past year. Concomitant medication(s) included: TAMIFLU taken for influenza (ongoing). Past drug history included: Evusheld for Protect against COVID, reaction(s): "Reactions", notes: Caller stated that her husband also took Evusheld to protect against COVID but had reactions to it. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "had 3 shots of the Pfizer COVID-19 Vaccine". The patient underwent the following laboratory tests and procedures: Influenza A virus test: Positive, notes: her husband had come back from travelling and tested positive for Flu A. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Wife of a male patient called asking if her husband can take Tamiflu with Paxlovid. He had been exposed to COVID patients including her and her son. He came back from travelling and tested positive for Flu A and was given Tamiflu. The person her husband travelled with also had COVID. His husband had 3 shots of the Pfizer COVID-19 Vaccine  and also took Evusheld to protect against COVID but had reactions to it. He had clotting disorders and also had spent 100 days in the hospital in the past year.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
recieved booster moderna on 10/22/21 with 0.25 ml.  10/30/21 had leg pain.  Dx'd with extensive DVT on 10/31/21.
Information concerning 3 children with varicella exposure who were vaccinated with one dose of varicella virus vaccine live.  Subsequently the pts developed breakthrough chickenpox after exposure to natural chickenpox in a day care setting. One pt developed full blown chickenpox. The other pt developed greater than 50 lesions. No details provided for the third child.
numbness on left side of face, left arm and pain in different places on left side started for shortly after vaccine. She has had all these symptoms prior but numbness never this bad. As of today, her symptoms are somewhat less. She has been able to work
I had typical fever, sore muscles, swollen lymph nodes that started about 5 hours after the shot and went away roughly 12 hours later. However, a loud ringing in my ears has replaced it. It?s loud, I can?t get it to stop, and it?s almost painful.
sugar before dinner and it was extremely high for me; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown), via an unspecified route of administration in the left arm on 20Mar2021 at 11:45 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes, high blood pressure, cholesterol and hypothyroidism. Concomitant medications included losartan (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN), ACTOS, PREMPRO, aspirin (MANUFACTURER UNKNOWN), hctz (MANUFACTURER UNKNOWN) on an unspecified date for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown), via an unspecified route in the right arm on 27Feb2021 (at the age of 53-years-old) at 09:00, as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.On 20Mar2021 at 18:00, the patient blood glucose increased. The patient normal blood sugar was between 132-165. After the vaccine she checked her sugar before dinner and it was extremely high for her. It was 263 (units unspecified) at 18:00. The patient did not receive any treatment for the reported event. The clinical outcome of the event blood glucose increased was unknown.   Information about lot/batch number cannot be obtained. No further information is expected.
got the shingles shot and got the shingles for 5 plus years/suspected vaccination failure; got the shingles shot and got the shingles for 5 plus years; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: got the shingles shot and got the shingles for 5 plus years/suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: got the shingles shot and got the shingles for 5 plus years). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 24-APR-2023 This case was reported by the patient's wife via interactive digital media. The reporter had stated that, her husband got the shingles shot and got the shingles for 5 plus years. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. Follow-up would not possible, as no contact, details were available.
Seizure and lost of consciousness 3 minutes after vaccine was administered. No treatment was given at pharmacy, but patient was taken by paramedics.
Dizzy, headache and vomiting after leaving the office within 20-30 min. Developed fever and dizziness and lethargy within 2-3 hrs. 6 hrs later felt better.
Complaint of tongue swelling, itchy, and dry mouth, Pt alert & oriented x 4, 4:40 PO Benadryl 25mg, Pt's symptoms resolved and left to go home.
Pt received vaccine Friday around 2:40pm and began with symptoms around 5pm that afternoon. Severe headache, extreme fatigue, joint pain, and injection site soreness. Symptoms were still present  on Saturday and were resolved by Sunday morning upon waking.